
Rosai-Dorfman Disease—Utility of 18F-FDG PET/CT for Initial Evaluation and Follow-up
Author(s) -
Sonia Mahajan,
Reiko Nakajima,
Mariko Yabe,
Ahmet Doğan,
Gary A. Ulaner,
Joachim Yahalom,
Ariela Noy,
Eli L. Diamond,
Heiko Schöder
Publication year - 2020
Publication title -
clinical nuclear medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.637
H-Index - 57
eISSN - 1536-0229
pISSN - 0363-9762
DOI - 10.1097/rlu.0000000000003014
Subject(s) - medicine , radiology , histiocytosis , nuclear medicine , positron emission tomography , pet ct , lesion , disease , pathology
The role of imaging in the management of Rosai-Dorfman disease (RDD), a rare non-Langerhans cell histiocytosis, is not clearly defined. We present an analysis of FDG PET/CT findings obtained for initial disease characterization, follow-up evaluation, and treatment planning for this disease.